Monthly Prescribing Reference

New Treatment for Partial-Onset Seizures Gets FDA Approval

Although its exact mechanism in the treatment of partial-onset seizures is unknown, cenobamate has been shown to reduce repetitive neuronal firing by inhibiting voltage-gated sodium currents. The Food ...
Forbes

XCOPRI Reduces Number Of Partial-Onset Seizures In Adults, Earns FDA Approval

Last week, the FDA approved XCOPRI (cenobamate tablets) to treat partial-onset seizures in adults. This approval will help offer additional aid for the many individuals throughout the world who live ...
Monthly Prescribing Reference

Fycompa Approved for Partial-Onset Seizures

Eisai announced that the FDA has approved Fycompa (perampanel tablets) as an adjunctive treatment for partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy ...
clinicaladvisor.com

Fycompa Approved for Younger Epilepsy Patients With Partial-Onset Seizures

child yellow pill medicine Safety data for Fycompa was consistent with the safety profile in adult populations without the need for weight-based dosing. The Food and Drug Administration has expanded ...
Becker's Hospital Review

FDA approves Eisai’s epilepsy drug for partial-onset seizures

The Food and Drug Administration on Wednesday approved Eisai’s epilepsy drug Fyompa as a primary treatment for partial-onset seizures in epileptic patients 12 years or older. Here are three things to ...
Investor's Business Daily on MSN

Xenon smashes its previous record high on 'unprecedented' results. Is a buyout next?

Xenon Pharmaceuticals stock launched Monday, hitting a record high, on "unprecedented" results for its seizure drug.
Healio

FDA approves XCOPRI for partial-onset seizures

Please provide your email address to receive an email when new articles are posted on . The FDA recently approved XCOPRI for adults with partial-onset seizures, its manufacturer announced. “The ...

Alzheimer’s prevention breakthrough found in decades-old seizure drug

Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken ...
Healio

FDA approves Briviact for young children with partial-onset seizures

Please provide your email address to receive an email when new articles are posted on . The FDA has approved an expanded indication for Briviact CV tablets, oral solution and injection, for treating ...
Medscape

CHMP Backs Generic Lacosamide UCB for Partial-Onset Seizures

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for the antiepileptic lacosamide UCB (UCB Pharma SA) for partial-onset ...
Nasdaq

Eisai's Anti-Epileptic Drug Fycompa Approved In China As Monotherapy For Partial-Onset Seizures And Pediatric Indication For Partial-Onset Seizures

TOKYO, Aug 2, 2021 - (JCN Newswire) - - Eisai Co., Ltd. announced today that its in-house discovered and developed anti-epileptic drug (AED) Fycompa (generic name: perampanel) has obtained two ...
News Medical

Briviact (brivaracetam) approved for treatment of partial onset seizures in patients with epilepsy

The U.S. Food and Drug Administration yesterday approved Briviact (brivaracetam) as an add-on treatment to other medications to treat partial onset seizures in patients age 16 years and older with ...